Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuronal nitric oxide synthase (nNOS) is one of three major isoforms of nitric oxide synthase (NOS), the enzyme family responsible for synthesizing nitric oxide (NO) from L-arginine. nNOS is constitutively expressed, primarily in neurons throughout the central and peripheral nervous systems, but also found in skeletal muscle and some other tissues. It catalyzes the conversion of L-arginine to NO and L-citrulline and is involved in synaptic plasticity, long-term potentiation, learning, and memory formation. Overproduction or dysregulation of nNOS-derived NO has been implicated in several disease states, making it a therapeutic target.
Selective inhibition of nNOS
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide synthase, neuronal isoform (nNOS).